Your browser doesn't support javascript.
loading
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Adebahr, Sonja; Althaus, Alexander; Scharl, Sophia; Strouthos, Iosif; Farolfi, Andrea; Serani, Francesca; Lanzafame, Helena; Trapp, Christian; Koerber, Stefan A; Peeken, Jan C; Vogel, Marco M E; Vrachimis, Alexis; Spohn, Simon K B; Grosu, Anca-Ligia; Kroeze, Stephanie G C; Guckenberger, Matthias; Fanti, Stefano; Hruby, George; Emmett, Louise; Belka, Claus; Schmidt-Hegemann, Nina-Sophie; Henkenberens, Christoph; Aebersold, Daniel M; Wiegel, Thomas; Afshar-Oromieh, Ali; Zamboglou, Constantinos; Shelan, Mohamed.
Afiliação
  • Adebahr S; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, German Cancer Consortium (DKTK), partner site DKTK-Freiburg, Freiburg, Germany.
  • Althaus A; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
  • Scharl S; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
  • Strouthos I; Department of Radiation Oncology, German Oncology Center, European University Cyprus, Nicosia, Cyprus.
  • Farolfi A; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Serani F; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Lanzafame H; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Trapp C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Peeken JC; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Vogel MME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Vrachimis A; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum, Munich, Germany.
  • Spohn SKB; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Grosu AL; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Kroeze SGC; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum, Munich, Germany.
  • Guckenberger M; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Fanti S; Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
  • Hruby G; C.A.R.I.C. Cancer Research & Innovation Center, Limassol, Cyprus.
  • Emmett L; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, German Cancer Consortium (DKTK), partner site DKTK-Freiburg, Freiburg, Germany.
  • Belka C; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Schmidt-Hegemann NS; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Henkenberens C; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, German Cancer Consortium (DKTK), partner site DKTK-Freiburg, Freiburg, Germany.
  • Aebersold DM; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Wiegel T; Radiation Oncology Center KSA-KSB, Canton Hospital of Aarau, Aarau, Switzerland.
  • Afshar-Oromieh A; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
  • Zamboglou C; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
  • Shelan M; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Eur J Nucl Med Mol Imaging ; 51(2): 558-567, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37736808

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha